, the Brentwood, TN-based centralized patient recruitment and retention company, announced the status of a current recruitment and retention program for a top pharmaceutical company currently studying a mental health issue in Phase III.

Praxis is providing services for two studies in Phase III, for which it had successfully completed a prior Phase III recruitment initiative. While the trials seek different patient populations, they are complimentary. Because of this, Praxis was able to develop an umbrella program for the sponsor under which both protocols can be effectively and simulatneously recruited. Based on the umbrella program, the sponsor was able to save $1.8 million in clinical program costs.

Praxis used both past experience in mental health studies, with the predictive modleing of its PraxisDirect 2.0 software  to design the program to meet enrollment goals. Nearly 2,000 patients will be randomized across 75 sites within a nine-month period. Praxis has experience with mental health areas including bipolar depression, major depressive disorder (MDD), and bipolar mania. 